Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Marie Skłodowska-Curie Action · Running

NUCLEAR Metabolic Regulation of Genome Function and Cell Identity

Coordinator
Fundacio Institut De Recerca Contra La Leucemia Josep Carreras, Spain
Runs
1 March 2025 to 28 February 2029
Status
Running
EU funding
€4.0m
Total cost
—
Partners
29 organisations in 10 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101166838

What the project is doing

In the project's own words, from its summary on CORDIS.

NUCLEAR aims at educating future experts that can drive the emerging field of Metabolic Regulation of Genome Function and Cell Identity relevant for stem cell biology and cancer. It is a Doctoral Training Network composed of 14 beneficiaries and 12 partner organisations including three industrial partners, a training-oriented foundation, a patient support association from 8 EU member states, 1 associated country and a non-EU member state self-funding itself to the level of beneficiary.

Given the highly interdisciplinary nature of this emerging field, no single institution can provide all suitable infrastructures and the know-how required for high-quality PhD-level training. To address this shortfall in training capacity, NUCLEAR brings together European leaders in metabolomics, functional genomics, chromatin regulation, stem cell biology and cancer with innovators in precision nutrition, mass spectrometry technologies and drug development.

Together we are committed to the following:1. To train 16 doctoral candidates (DCs) through an innovative program structured in four capacity axes and occurring on three complementary levels to deliver enabling scientific and transferable skills.2. To guide DCs in collaborative research bridging boundaries of countries, sectors, and disciplines.3. To address three key challenges that limit the advancement and exploitation of the field and that are the lack of tools to measure nuclear metabolism, the lack of understanding of underlying molecular mechanisms and the lack of targets for novel cancer therapies. 4.

To build lasting infrastructures for dissemination, communication and exploitation promoting an entrepreneurial culture and maximizing and extending the impact of this proposal beyond its lifetime. 5. To increase the international visibility of European research by taking leadership in the emerging field of Metabolic Regulation of Genome Functions and Cell Identity.

Topics

Who is involved

OrganisationCityCountryRole
Fundacio Institut De Recerca Contra La Leucemia Josep CarrerasBadalonaSpainCoordinator
University of CyprusNicosiaCyprusParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyAssociatedpartner
Eisbach Bio GmbHPlanegg- MartinsriedGermanyParticipant
Leibniz-Institut Fur Analytische Wissenschaften-Isas-EvDortmundGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyAssociatedpartner
Max Delbrueck Centrum Fuer Molekulare Medizin in Der Helmholtz-Gemeinschaft (mdc)BerlinGermanyParticipant
Thermo Fisher Scientific (bremen) GmbHBremenGermanyAssociatedpartner
Universitaet Duisburg-EssenEssenGermanyAssociatedpartner
Kobenhavns UniversitetKobenhavnDenmarkParticipant
Asociación Española Contra el CáncerMadridSpainAssociatedpartner
Fundacio Centre De Regulacio GenomicaBarcelonaSpainParticipant
Precision Forhealth SLMadridSpainParticipant
Universidad Autonoma De MadridMadridSpainAssociatedpartner
Universidad Pompeu FabraBarcelonaSpainAssociatedpartner
Universitat Autonoma De BarcelonaCerdanyola Del VallesSpainAssociatedpartner
Istituto Europeo Di Oncologia SRLMilanoItalyAssociatedpartner
Universita Degli Studi Di MilanoMilanoItalyParticipant
Stichting Radboud UniversiteitNijmegenNetherlandsParticipant
Stichting ScilinkAmsterdamNetherlandsAssociatedpartner
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Universiteit UtrechtUtrechtNetherlandsAssociatedpartner
Universitetet I BergenBergenNorwayParticipant
Universitetet I Tromsoe - Norges Arktiske UniversitetTromsoNorwayParticipant
King Abdullah University of Science and TechnologyThuwalSAAssociatedpartner
Karolinska InstitutetStockholmSwedenParticipant
Stockholms UniversitetStockholmSwedenParticipant
The Babraham InstituteCambridgeUnited KingdomAssociatedpartner
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI